Is Advanced Health Intelligence Ltd (AHI) a Buy, Sell, or Hold?
NASDAQ : AHI
Advanced Health Intelligence Ltd — News
$1.5 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 196
- Market Capitalization
- $345.76M
- P/E Ratio
- -3.85
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.50
- Year Low
- $1.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.06
| Source | Headline |
|---|---|
|
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and i
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demo gurufocus.com - 2026-06-06 15:00:00 |
